Figure 1.

Percentage of responders to 12 weeks of daily eluxadoline.³⁸ Responders were defined as patients with a ⩾30% decrease from baseline in worst abdominal pain for ⩾50% of days, and, on the same days, a Bristol Stool Scale score <5.

BID, twice daily.